Background Multiple early reports of patients admitted to hospital with COVID-19 showed
that patients with chronic respiratory disease were significantly under-represented in these …

Background Despite hospitalization for exacerbation being a high-risk event for morbidity and
mortality, there is little consensus globally regarding the assessment and management of …

Cancer is a leading cause of mortality worldwide. Over 50% of cancers are diagnosed late,
rendering many treatments ineffective. Existing liquid biopsy studies demonstrate a minimally …

Background COPD and asthma exacerbations result in many emergency department
admissions. Not all treatments are successful, often leading to hospital readmissions. Aims We …

Background The lack of standardised outcome assessments during hospitalisation and
follow-up for acute COPD exacerbations has hampered scientific progress and clinical …

Background: The extent to which treatment of a COPD exacerbation reduces patients’
dyspnoea is highly variable. Characterising dyspnoea trajectory patterns or ‘trajectotypes’ could …

Background: Systemic corticosteroids (SCS) are recommended for exacerbations of asthma
& COPD in a ‘one size fits all’ strategy. We investigate features associated with the physician …

Chronic obstructive pulmonary disease (COPD) affects millions of people worldwide. It is
now clear that COPD is heterogeneous, different components of the disease being present in …

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
worldwide. Progressive in nature, COPD is punctuated by acute periods of worsening termed ‘…

Background: Treatment of an exacerbation of COPD is not always successful. Identifying
symptoms that associate with a treatment success could improve outcomes Objectives: To …